M&A business
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Of course they can - I just explained it.
Either you go with the new rules or you are left behind.
The same happend to Chrysler or a lot of other companies especially in the financial industry but then as well in the movie industry.
Perfect Timing.
MLFB with a new Team, new professional advisors and more had to do, what a lot of companies have to do: Respond to the challenges.
This is something that made the American Industry strong. The car industry had to respond to the Asian competition and the Airlines Industry had to respond to the deregulation within the international aviation industry and the finance-industry had to respond to the new regulations of the sarbanes Oxcley act.
From the weak spot to the strong spot. Only those that do not react will be left behind. MLFB had to react as well with reference to the relationship with NFL
The Company has agreements with both agencies to pay a minimum per month to avoid any collections or additional liens.
All part of the filings.
THIS IS A VERY OLD CASE FROM 2003 AND HAS BEEN DISMISSED IN 2005
http://securities.stanford.edu/filings-case.html?id=102946
Experience cannot be denied. And of importance: The new Team showed up in 2014 -
The CEO Jerry Vainisi as former General Manager of the Chicago Bears should certainly understand the Business.
And Wes Chandler as President is the current NFL record holder in receiving per game (129 in 1982) and was inducted into the San Diego Charger Hall of Fame. Mr. Chandler has coaching experience at every level of play including 7 years in NFL Europe (coach of the Berlin Thunder in 1999), Dallas Cowboys, Minnesota Vikings and Cleveland Browns.
http://www.b2i.us/profiles/investor/Management.asp?BzID=2245&to=mb&Nav=0&LangID=1&s=0
Somehow it did not come as a surprise to me, that the From 15-12G yesterday was not understood by some and all of a sudden there was talk of delisting and more.
But if one would have read the filing, then it would have been clear, DECN only did what a lot of other companies have done in the past : Termination of Registration or suspension of duty to file reports.
THE EXPRESSION TERMINATION OF REGISTRATION OR SUPSENSION OF DUTY TO FILE REPORTS, has 2 meanings. A company could go the road of other companies and file under OTC Disclosure forever or after a certain period return to the regular SEC Filings. For this the words: Termination AND OR Suspension should be read and not be left out.
Recommend is certainly this FAQ – which tries to explain the suspending-reporting-obligations.
http://media.mofo.com/files/Uploads/Images/FAQ-Suspending-Reporting-Obligations.pdf
What can happen if not understood what those rules are all about, became visible yesterday when some people sold the stock and right into the hand of those who understood the rules.
The same can be said about the O/S of 46 Mio shares which gave cause to debate, but the wrong way. The O/S presents the status-quo of all shares out (has nothing to do with the Float by the way) and it does not matter if the O/S was created by issuing new common shares for financing or if the common shares O/S was increased through the conversion of preferred shares into common shares as well due to financing. A lot of balance-sheet show items as Preferred shares, Warrants, Options and Common shares or Treasury shares reserved for CV’s. And as every professional knows when reading those balance-sheets: One day, those various classes could be converted in common shares unless of course with Warrants and Options or CV’s ,if the strike would never be reached for execution.
Having said this: The DECN management did an outstanding job, navigating DECN through this 3 year process and was able to get financed in an orderly manner. This court battle was not cost free. I am always surprised when reading comments against DECN on this behalf, but with no solutions how a company could have carried all those legal costs and other expenses, without debt or equity. Tried to consult books, but on this subject even experts have no other solutions than debt or equity. And therefore, unless capitalism switches to idealism, costs/expenses will have to be paid somehow and by somebody.
The balance-sheet is healthy with plenty of cash in the bank: Cash of $ 1.750.000 and then receivables of $ 267.000. In total DECN has roughly 2 Mio Cash in the Bank. Not bad I would say.
And we should not forget the notes payable of $ 2.2 Mio will be something, J&J will have to cover by a multiplication factor X. .
Conclusion: Due to this new filing we will very soon get the restriction on OTC lifted. It will then read: OTC Pink current Information. And all further filings will be under section: OTC Disclosure. This is all.
Once this process is through, certainly we can expect the announcement of the acquisition of assets and some more excellent news which should give a feel-good moment to all DECN shareholders.
Bravo DECN
For my point of view, DECN should have done this before. The law permits this road and actually there are plenty of companies listed under “OTC Pink Current Information”. Nothing will change as a matter of fact. DECN still will be reporting but not under SEC Filings but under OTC Disclosure & News Service.
So the question by some is: Why did DECN chose this road. There are many reasons why companies are choosing this road but with DECN it is rather very simple. They had bad luck with their auditor company (together with other clients from this accounting firm) This former auditor company had to close the doors and some of those accountants are under investigation. So why should their former clients suffer and have to Spend 100.000ths of $’s for re-audit all the way back ? Does not make sense at all, so the solution is and was, take the road the SEC allows every company if and when certain criterias are meet. And DECN meets those criterias.
Does it hurt the shareholders? Nope absolutely not. I welcome everybody to tell me, why it should hurt the shareholder. The information flow will exactly be the same only the responsibility from the reports will be carried on one shoulder: The CEO of the company . And believe me, a CEO of the company has no interest to issue reports stamped with his signatures, when he is not double sure that all is reported as it has to be. The 4 or 6 eye princip will Count in this case as well.
In a way strange that some may think, that DECN would now be in a position of disadvantage and could not even upgrade. Rather on the contrary. They even have an advantage and they can upgrade. Critics should ask the question: Why the law should allow foreign firms going this road but then not US-based firms? A lot of reporting foreign companies – and I am talking here about billion-dollar companies left the quarterly reporting road and chose to join this segment.
Thus, DECN will become OTC Pink current information.
Companies that follow the International Reporting Standard or the Alternative Reporting Standard by making filings publicly available through the OTC Disclosure & News Service pursuant to OTC Pink Basic Disclosure Guidelines. The Current Information category is based on the level of disclosure and is not a designation of quality or investment risk.
Under the Pinky segment you will find a lot of companies who have capitalisation of $ 500 Mio up to 3 billion.
http://www.otcmarkets.com/market-activity/current-otc-market
Finally: Will it keep buyers away? Why should it. I have not found one company who chose this road, that they got hurt in the stockprice on the contrary all of them are in prices higher today than they were before. DECN can now fully concentrate on their J&J case on one hand and on the other hand on their business-side and prepare all what is necessary for an upgrade. Believe me: DECN has proven to chose the right legal advise in the causa J&J and they will certainly have an excellent advise from a SEC lawyer as well helping them to achieve the upgrade level.
Experience cannot be denied. And of importance: The new Team showed up in 2014 -
The CEO Jerry Vainisi as former General Manager of the Chicago Bears should certainly understand the Business.
And Wes Chandler as President is the current NFL record holder in receiving per game (129 in 1982) and was inducted into the San Diego Charger Hall of Fame. Mr. Chandler has coaching experience at every level of play including 7 years in NFL Europe (coach of the Berlin Thunder in 1999), Dallas Cowboys, Minnesota Vikings and Cleveland Browns.
http://www.b2i.us/profiles/investor/Management.asp?BzID=2245&to=mb&Nav=0&LangID=1&s=0
Sometimes it is good to be Patient before replying.
By your standarts all should be perfect.
But just to give one example about the past:
Apple almost went bankrupt in 1996 because it failed to innovate. Where is Apple now?
http://www.macrumors.com/2011/09/19/steve-jobs-apple-almost-went-bankrupt-because-it-failed-to-innovate/
And what happend to Steve Jobs. Wasn't he sued for backdating Options.
http://www.informationweek.com/it-strategy/apple-steve-jobs-executives-board-sued-for-securities-fraud/d/d-id/1069478?
I took MLFB up some weeks ago, not because of the past, but because of a new start and I guess, MLFB learned a lot what could be done better in this Business filled with sharks.
And by the way: Bayern Muenchen today, one of the most succesfull Club in the world was on the brink of bankruptcy not only once but twice and other famous names as well in the European Football league.
A balance-sheet will not help in this Business as I already posted before. It is all about contracts.
I friend of mine who understands and is a big fan and supporter (even as Sponsor) of American Football - compared to me who is a fan of European Football and a fan of Real Madrid and Bayern Muenchen - attended a presentation in California and another one at the East Coast. They are in talk with some big Names in the TV industry. What Comes out of it is a guess-game but I would say, with some of the professional People involved here some signatures could come out of it.
The old rule in this Business: Sign the contracts and the Money will follow.
By the way: Real Madrid and Barcelona are writting heavy red figures but if somebody would buy them out, we would be talking 1 Billion plus.
The Sport Industry cannot be compared with the rules of old economy. I may be very early here - but if they can bring those contracts home - they will be covered by Venture Capital.
Let's see.
Wes Chandler, President of MLFB - was named as 2015 College Football Hall of Fame Inductee.
Seems, that such a prestigious lifetime honor is something somebody can be proud of.
And it Shows something more: That MLFB besides him is a Company well equipped with former professional heavyweights who have the right Connections.
But then as always, there will be People consider this Company as a pump Company and nothing more. I would advise those first to present us with a CV which would give them the right to make fun of those People who have a place in the American Football history.
Based on a conversation this is what they have in mind as well and for this reason the opened a contact in the U.K. But I think, first they have to concentrate on the USA market and getting those contracts signed which will guarantee a success.
I guess they are in negotiation presently for a debt-project (not dilutive) which could or would be backed through certain expected Revenue channels.
But as I said, I think we gonna hear more in the weeks ahead, but the stock is certainly worthwile to Keep on the watchlist and I grabbed some and will add more if the news-flow is supportive.
They merged MLFB in the third quarter into this Shell. They should have Chosen a better Price but at the same time it was a 5 to 1 split.
From this Point of view, I think the Level of $ -.20 - -.40 would have reflected the right Price.
The way my Interpretation is: It was merged into this Company and then the Price adjusted.
Best is to get it from here.
http://www.mlfb.com/
http://www.mlfb.com/#spring-football
The way I see it, they are filling the gap of the dead-season like we have in Europe and South-America with Football. For the FIFA and the European Football Clubs a Billion Dollar Business of course and I guess in the USA would be the same.
If they execute as planned it will become a very real Company. As time goes by it should become more and more visible.
Some good stuff on this board.
I needed some time to Digest the News. All what I can say: J&J fasten your seat-belts.
The market may be dormant presently when it Comes to DECN due to the fact, that this case went on for so Long. But, who would have expected at the start that DECN would survive? And who would have expected at the start that DECN would Corner J&J in a Situation where they could face not only patent losses with consequences I do not have to Elaborate, but as well could be confronted with a damage Claim, they never thought of.
I would say; once the press takes this subject up when the dust has settled and being understood after this Long back and forth battle, DECN could become attractive to some based on the speculation how much $'s will be added to the Treasury and then what is ahead for DECN as operative Company.
Besides this, I hope that OTC soon will gona lift this sign OTC Pink limited Information to OTC pink Current Information. They would certainly deserve this.
Life is full of surprises.
Personally I believe the Company will (could) be saved with an alliance that could surprise some. But certainly no room for the old guard like B.S. and L.B.
Sometimes - to stay with Machiavelli - build an alliance with somebody which would have been considered some time ago unholy, but then at least has somehow proven that one can build a Company from start, with Little Money but Quality. Who knows.
Not over yet.
Weather is nice and spring all over the place.
What spring season can do for the mind is known, what is not known, what will happen with all those Shares constantly being bought all the way down.
I have a theory about all this, but then as we know, theories leave room for all Kind of speculation and I prefer not to be part of it.
It is interesting to see, how DECN stock reacted since March 4th when DECN rejected the Settlement offer from J&J and other News started to move in.
Obvious to see, that during this cycle it was certainly more rewarding to own DECN than J&J. (as well as other Major Indexes)
So all those Newcomers who reacted on March 4th when the first News came out, certainly have no reason to complain, compared to those who stayed inactive because they could not believe, that such a small Company would refuse a Settlement offer from the giant J&J as too low.
The 1.5 month Performance 20 % and the 1 month Performance 56 %. Not bad at all.
This Chart was presented on March 16th.
I would say, at least, congratulations could be expected for the timely advise. Those who acted made a nice return.
For months we were entertained, that DECN is close to bankruptcy, has no cash and due to the uncontrolled conversion of preferred shares into common shares the O/S would be closer to 80 Mio.
Well – well. All wrong. The O/S is almost 50 % less and there is plenty of Cash in the bank.
With all the financing going on over the last 2.5 years, the O/S is around 47 Mio.
Then if we take the Cash of $ 1.750.000 and the receivables of $ 267.000 we can say, DECN has roughly 2 Mio Cash in the Bank. Not bad I would say.
And we should not forget the notes payable of $ 2.2 Mio will certainly be covered many times from J&J.
We know, that DECN received a settlement offer and we know, that DECN refused the offer. What we know as well, a settlement offer has 2 amounts: 1 Amount to pay for all the legal expenses. As DECN already pre-financed the legal expenses – this money will be added to cash. And then comes the second amount: calculated based on the possible damage of the blockade with a formula times 2 or 3.
The intervention from the U.S Solicitor General means that DECN (Pharmatech) as a matter of fact, will have the support from the highest US Federal Agency in the court and this of course will increase the settlement amount. By how much, I have no idea, but we are talking here some more millions. At the end, it will be cash in the bank.
DECN is preparing itself for a very bright future.
Yesterdays news of course were not welcome news for everybody but certainly for DECN shareholders.
Those familiar with the case or better said only interested in the legal battle between J&J and DECN must admit, that this recent development was never part of a script as it shows, what can happen when big money thinks, that the rules are for everybody but then not for themselves and try to turn the clock back 100 years.
The attacking of the USPTO decision by J&J after having lost 3 times is a clear sign, that they regard this office not as a federal agency and worse, disregard the Constitution of the USA.
They better would read what The United States Patent and Trademark Office presents.
The USPTO fulfills the mandate of Article I, Section 8, Clause 8, of the Constitution that the legislative branch "promote the Progress of Science and useful Arts, by securing for limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries." The USPTO registers trademarks based on the commerce clause of the Constitution (Article I, Section 8, Clause 3). Under this system of protection, American industry has flourished. New products have been invented, new uses for old ones discovered, and employment opportunities created for millions of Americans. The strength and vitality of the U.S. economy depends directly on effective mechanisms that protect new ideas and investments in innovation and creativity. The continued demand for patents and trademarks underscores the ingenuity of American inventors and entrepreneurs. The USPTO is at the cutting edge of the nation's technological progress and achievement.
The USPTO advises the president of the United States, the secretary of commerce, and U.S. government agencies on intellectual property (IP) policy, protection, and enforcement; and promotes the stronger and more effective IP protection around the world. The USPTO furthers effective IP protection for U.S. innovators and entrepreneurs worldwide by working with other agencies to secure strong IP provisions in free trade and other international agreements. It also provides training, education, and capacity building programs designed to foster respect for IP and encourage the development of strong IP enforcement regimes by U.S. trading partners.
If one takes this “intus” then it cannot come as a surprise, that The office of the Solicitor General had to intervene and now actually is joining the Pharma Tech attorneys in their battle against J&J. The verdicts (wordings) from USTPO against J&J in this case were more than clear and one thinks that the first ruling should have had the necessary effect, nope even 3 rulings against J&J were not taken serious on the contrary, J&J tried their old known strategy backed by unlimited resources under the slogan “ we are the system”.
The old saying: You can “F” everybody but never “F” with the government as the latter has more rescources as those so-called monopolists.
The filing from the Solicitor General of the USA about his intention to intervene in the United States court of Appeals for the Federal Circuit should make it clear: That the time is running out for J&J and actually they missed the perfect exit. Now it will become very very expensive for them, but as one lawyer stated in an UK forum: J&J will only learn when the penalty really hurts because as a public company they will be responsible to a body representing the shareholders. How will they justify a case that never should have taken place but has cost them already millions in legal fees. How will the justify their tactics in a case which was lost already some months ago, however out of stubbornness was not settled and now at risk to add more and more millions for legal fees and settlement costs? Regardless what kind of capitalization J&J has, there are clearly limits within each organization when it comes to throw money out of the window. They should have learned from all those Anti-Trust cases some of the big companies went through in the USA and in Europe and at the end had to pay millions and millions. Seems they did not and the reason can only be found in this little story:
They thought of DECN as a small company run by a bunch of unguided missiles. Their thinking was bolstered by Emails/information they got from 3 to 5 parties who had an old open bill with DECN and the management. And J&J fell into this trap. They bought those stories 1 to 1 and even hired a “paid and fake” expert for testimony. But what they missed by first believing all those unfound stories was the fact, that DECN was well advised from the start from some of the best legal brains (as certainly proven now) and as well were backed by some strong hands of investors signaling them the full support. Those are the supporters that are not reading the daily gossip press in some forums against DECN but concentrate on what matters: Win, cash in and execute and grab as much from this huge market as you can and J&J tried at all cost to prevent. And this kind of prevention should make it clear to everyone: There is more to gain from the market DECN tries to penetrate than the eyes presently meets – and J&J knew it and therefore made one of their biggest mistake: Getting in clinch with an Federal Agency.
And in case, somebody would not know what the Solicitor General of the USA means:
The United States Solicitor General is the person appointed to represent the federal government of the United States before the Supreme Court of the United States. The current Solicitor General, Donald B. Verrilli, Jr., was confirmed by the United States Senate on June 6, 2011, and sworn in on June 9, 2011.[1][2] The Solicitor General determines the legal position that the United States will take in the Supreme Court. In addition to supervising and conducting cases in which the government is a party, the office of the Solicitor General also files amicus curiae briefs in cases in which the federal government has a significant interest in the legal issue. The office of the Solicitor General argues on behalf of the government in virtually every case in which the United States is a party, and also argues in most of the cases in which the government has filed an amicus brief. In the federal courts of appeal, the Office of the Solicitor General reviews cases decided against the United States and determines whether the government will seek review in the Supreme Court. The office of the Solicitor General also reviews cases decided against the United States in the federal district courts and approves every case in which the government files an appeal.
I know only 2 cases where they intervened.
This is now the third. Congratuations to the DECN Management.
U.S. Solicitor General Intervenes Against Johnson & Johnson in DECN's Long Running Patent Battle Over GenStrip 50
Interventions by the Solicitor's Office to Protect the Rights of a Corporation Are Rare
That DECN refused the Settlement offer was brilliant. Won't get cheaper.
I love this one.
Since the fundamental premise of the latest J&J/Lifescan appeal concerns the propriety, conduct and legality of the actions and decisions of the USPTO, the United States government has joined Pharma Tech in the pursuit of its final litigation victory. The Solicitor General of the United States, Donald B. Verrilli, Jr., has filed a notice of an intention to intervene in the United States Court of Appeals for the Federal Circuit. The Office of the Solicitor General will now join the Pharma Tech attorneys to finally and thoroughly extinguish their '105 patent infringement allegations.
Keith Berman continued, "We are now embarking on the final phase of this patent litigation. The legitimacy of our positions concerning the former J&J '105 patent have already been repeatedly acknowledged by the courts and we are confident they will once again be vindicated in the Federal Circuit Court of Appeals. Although we did not require the assistance of the Solicitor General to prevail, the support of the United States government is a vocal rejection of J&J's positions and an apparent condemnation of the strategy that has been employed against us. We welcome the presence of the Solicitor General and look forward to working together with the United States government to complete our victory."
Acquistion of Assets and more.
The question how DECN would/could finance the acquisition of assets, will certainly soon be disclosed. But the wording “assets” in their NT10K filing from last week is clear: The Registrant’s subsidiary Pharma Tech Solutions, Inc. is completing an acquisition of certain healthcare assets from a
privately owned concern and this event also includes changes of registration with federal regulatory bodies as well as primary private registrars.
This event transaction closing is expected to be completed by April 14, 2014. In short, this is not about an acquisition of a company, it is about an acquisition of Assets and under assets a lot could be understood and I could even speculate here about what the Assets could be and if my nose is right, it could be a surprise. But, very soon, we will know for sure,without entering speculation.
Based on the past, DECN avoided debt-financing which from a balance-sheet point of view has been smart. If then so, I guess, DECN will do equity financing as most of the companies are doing when they make an acquisition and if the acquisition adds value to the company in the future, then the dilution should be well balanced I would guess. What I do not understand the recent hoopla about the issuance of preferred – or common shares to get financed. Well at the end it is the same: With common shares it is the 1 to 1 factor and with preferred shares one has to calculate the factor based on the given ratio and maybe of interest as well , if those shares would have certain rights, like voting rights or whatever, but the end result is clear from the start when it comes to calculate the dilution by simply multiplying the given factor from PFD to Common.
THIS PART I READ ON ANOTHER BOARD AND I LOVE IT.
There are now 3 lawyers assigned to counter the J&J appeal by the Federal government. Two top lawyers from the USPTO have been assigned to assist the topest lawyer of all from the Solicitor General's office who will sign the government's briefs and make the arguments in open court. All three lawyers assigned have clerked for judges in the Circuit (patent) court, and cut their teeth writing the opinions made by the Circuit Court. This is a veritable high level legal Who's Who aligned against J&J.
The conclusion from this message would then be: The government has even more resources than J&J and it would be advisable to take notice, that this time the government is on the side of DECN. Seems DECN has done something right or better said, the Management of DECN handles this case in the most professional way.
Wondering what Kind of acquistion they will announce but it Shows to me, they are full power ahead and what is best, DECN has the backing of some strong shareholders to do all this. If this is not a sign of trust - what then?
And soon, those big shareholders will be rewarded with Performance as the rope around the neck of J&J is getting tight.
The Registrant is unable to file its quarterly report on Form 10-K within the prescribed time period due to a material event now in
process. The Registrant’s subsidiary Pharma Tech Solutions, Inc. is completing an acquisition of certain healthcare assets from a
privately owned concern and this event also includes changes of registration with federal regulatory bodies as well as primary private
registrars. This event transaction closing is expected to be completed by April 14, 2014.
Decision Diagnostics Corp.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
By: /s/ Keith M. Berman
Keith M. Berman, Principal Executive Officer
(3)
Date: March
Execellent news as a matter of fact and thank you for posting this.
Why do I come to this conclusion?
Here step by step
.
Gotham Insurance Company does not want to pay. As it says: Plaintiff has submitted evidence that it faces exposure to multiple liability, and has averred that it is a disinterested party with no claim to the insurance proceeds.
In plain Englisch: Gotham Insurance is facing claims to pay. And paying to whom? Each defendant has filed a claim with plaintiff, asserting that they are entitled to the insurance proceeds. And as Gotham does not want to pay, they sued those who made the claim to be paid: And who are the defendants: SHASTA TECHNOLOGIES, LLC, INSTACARE CORP., and PHARMATECH SOLUTIONS, INC.
Now based on the court order: Gotham will not have to pay to or better said, the claims of
Shasta Technologies, LLC, Calvin Knickerbocker, Jr. and Calvin Knickerbocker III, have been dismissed.
But there is nothing written, that the claims from Instacare Corp (now DECISION DIAGNOSTICS) and Pharmatech Solutions have been dismissed.
It is always recommended when reading legal texts, to read all as the interpretation of court-orders is a very complex matter and easily misunderstood. Based on this, DECN and Pharmatech Solutions could still get some money, nobody ever thought about. Indeed a very nice present.
For the sake of good order, this is what it says:
Based on the foregoing facts and the stipulation of the parties, IT IS ORDERED THAT:
1. The Clerk of the Court shall enter a final decree of interpleader in favor of Plaintiff Gotham Insurance Company;2. Plaintiff Gotham Insurance Company is dismissed from this case with prejudice;3. All of the claims of Defendant and Counter-claimant Shasta Technologies, LLC contained in its Answer and Counter-claim filed on September 15, 2014, against Plaintiff and Counter-defendant Gotham Insurance Company are dismissed with prejudice;4. From Plaintiff Gotham Insurance Company's First Amended Complaint, the Third Cause of Action for Breach of Written Settlement, Fourth Cause of Action for Promise Made with No Intention to Perform, and Fifth Cause of Action for Fraud, against Defendants Shasta Technologies, LLC, Calvin Knickerbocker, Jr. and Calvin Knickerbocker III, respectively, are dismissed with prejudice
NO WORDING OF INSTACARE (NOW DECN) OR PHARMATECH or better said, that their claim was dismissed.
But it is not finished here: However, should Plaintiff institute any action against Defendants, Defendants shall retain the right to assert all defenses, including affirmative defenses, and, Defendants shall retain the right to file and prosecute any cross-claim in such action by Plaintiff, whether compulsory or permissive, provided that the facts and events giving rise to any such cross-claim must have occurred after the date on which this order was entered.
Conclusion: Instacare (now DECN) and Pharmatech are still in the game for their claim and Gotham is somehow in a straitjacket as if a cross-claim should show up, and it certainly will, they all of a sudden would face again claims from the rest. My guess: Good old Gotham will possibly have to pay some money to DECN and or Pharmatech. How much is not of interest but money is money.
I have read, that there is a second J&J case related to their Ethicon Division going on in exactly the same Position. This case should be heard about 3 weeks before the DECN case will be heard. This could be an huge Advantage for DECN being dealt with afterwards. Why: Internas from the pre-case certainly would go out and make the round.
Then let's go to Las Vegas
http://finance.yahoo.com/news/major-league-football-inc-present-123000949.html